1 day ago · SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued Final Written Decisions invalidating all claims in 10x Genomics’ 10,697,013 and 10,240,197 ...

2 days ago · Coupled with the invalidation of 10x Genomics’ 10,155,981 patent last year, Parse has now invalidated all claims that 10x Genomics asserts against Parse products, further reinforcing Parse’s ...

2 days ago · Parse has now invalidated all claims that 10x Genomics asserts against Parse products, further reinforcing Parse’s ability to drive ongoing innovation in the single cell space.

1 day ago · Parse Biosciences, which has now triggered invalidation of three 10x Genomics patents in response to being sued for infringement, said it was a "significant legal victory." Parse Biosciences, which has now triggered invalidation of three 10x Genomics patents in response to being sued for infringement, said it was a "significant legal victory." ...

1 day ago · Parse Biosciences Inc. convinced an administrative tribunal to invalidate two 10x Genomics Inc. cell-analysis patents its products are accused of infringing. 10x’s US Patent Nos. 10,240,197 and 10,697,013 are obvious in light of two prior patent applications and a scientific journal article, according to decisions issued Jan. 31 and Monday by ...

2 days ago · The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) has issued two final decisions in a patent infringement lawsuit brought by 10x Genomics against single-cell sequencing firm Parse Biosciences ruling that all claims associated with two patents were invalid.

Sep 18, 2024 · In its decision to invalidate the 10,155,981 Patent, the PTAB rejected 10x Genomics arguments in response to the Inter Partes Review petitioned by Parse and ruled that all claims are unpatentable.

Sep 14, 2023 · Genomics startup Parse Biosciences lost its bid to dismiss a patent-infringement lawsuit brought by rival 10x Genomics and Stanford University on Thursday, when a Delaware federal court...

Sep 18, 2024 · Parse announced that the Patent Trial and Appeal Board issued a decision to invalidate all claims in the 10,155,981 patent asserted by 10x Genomics.

10x Genomics Inc. defeated Parse Biosciences Inc.’s bid to dismiss a lawsuit over improved ways to analyze genetic information, as a federal judge rejected the startup’s arguments for voiding six patents, including three 10x licenses from Stanford University.